Stock 688133 SHANGHAI TITAN SCIENTIFIC CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Shanghai Titan Scientific Co., Ltd.

Equities

688133

CNE100005XG3

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
26.65 CNY -1.73% Intraday chart for Shanghai Titan Scientific Co., Ltd. -5.73% -42.50%
Apr. 29 Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 21 Shanghai Titan Scientific Co., Ltd. agreed to acquire 30% stake in Shanghai Magal Scientific Instrument Co., Ltd. from Wu Gang and Ling Hui. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Shanghai Titan Scientific Co., Ltd. agreed to acquire 30% stake in Shanghai Magal Scientific Instrument Co., Ltd. from Wu Gang and Ling Hui.
CI
Shanghai Titan Scientific Co., Ltd. agreed to acquire 26.6667% stake in RADOBIO Scientific Co., Ltd.
CI
Shanghai Magal Scientific Instrument Co., Ltd. announced that it expects to receive CNY 12 million in funding from Shanghai Titan Scientific Co., Ltd., Shanghai Titan Heyuan I Venture Capital Investment Partnership Enterprise (Limited Partnership)
CI
RADOBIO Scientific Co., Ltd. announced that it expects to receive CNY 16 million in funding from Shanghai Titan Scientific Co., Ltd., Shanghai Titan Heyuan I Venture Capital Investment Partnership Enterprise (Limited Partnership)
CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Shanghai Titan Scientific Co., Ltd.(XSSC:688133) added to S&P Global BMI Index
CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Milestone® Biotechnologies announced that it has received CNY 100 million in funding from Haichuang Tiancheng Equity Investment Fund Management Co., Ltd., Jiangsu Addor Equity Investment Fund Management Co., Ltd., GL Ventures, Shanghai Titan Scientific Co., Ltd., Jiaxing Tongyu Private Equity Fund Management Co., Ltd.
CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688133 Stock
  4. News Shanghai Titan Scientific Co., Ltd.